These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 4836611

  • 1. Chloroquine-induced ocular toxicity.
    Petrohelos MA.
    Ann Ophthalmol; 1974 Jun; 6(6):615-8. PubMed ID: 4836611
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Chloroquine retinopathy.
    Easterbrook M.
    Arch Ophthalmol; 1991 Oct; 109(10):1362. PubMed ID: 1929921
    [No Abstract] [Full Text] [Related]

  • 5. The blood-retinal barrier in chloroquine retinopathy.
    Raines MF, Bhargava SK, Rosen ES.
    Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1726-31. PubMed ID: 2759787
    [Abstract] [Full Text] [Related]

  • 6. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C, Bechetoille A, Ebran JM.
    J Fr Ophtalmol; 1983 Aug; 6(8-9):689-95. PubMed ID: 6677659
    [Abstract] [Full Text] [Related]

  • 7. [Ocular changes caused by long-lasting use of chloroquine and its derivatives in rheumatoid disease].
    Drewnowska-Sochańska A, Kuprianowicz W, Petrus B.
    Klin Oczna; 1970 Aug; 40(4):499-503. PubMed ID: 5453064
    [No Abstract] [Full Text] [Related]

  • 8. Chloroquine and hydroxychloroquine retinopathy: how to follow affected patients.
    Ruiz RS, Saatci OA.
    Ann Ophthalmol; 1991 Aug; 23(8):290-1. PubMed ID: 1952637
    [Abstract] [Full Text] [Related]

  • 9. Ophthaproblem. Chloroquine or hydroxychloroquine retinopathy.
    Liu W, Sharma S.
    Can Fam Physician; 2005 May; 51(5):671, 679-80. PubMed ID: 15934269
    [No Abstract] [Full Text] [Related]

  • 10. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM.
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [Abstract] [Full Text] [Related]

  • 11. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
    Bernstein HN.
    Am J Med; 1983 Jul 18; 75(1A):25-34. PubMed ID: 6869408
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ophthalmologic considerations in using antimalarials in the United States.
    Rynes RI.
    Lupus; 1996 Jun 18; 5 Suppl 1():S73-4. PubMed ID: 8803917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Screening for antimalarial toxicity.
    Easterbrook M.
    Can J Ophthalmol; 1993 Apr 18; 28(2):51-2. PubMed ID: 8508335
    [No Abstract] [Full Text] [Related]

  • 16. Pigmentary skin changes associated with ocular chloroquine toxicity in Ghana.
    Bentsi-Enchill KO.
    Trop Geogr Med; 1980 Sep 18; 32(3):216-20. PubMed ID: 7210154
    [Abstract] [Full Text] [Related]

  • 17. RE: Author reply:
    Martínez-Costa L, Trentini FJ, Ibañez MV, Murcia-Bello C, Epifanio I, Verdejo-Gimeno C, Beltrán-Catalán E, Marco-Ventura P.
    Can J Ophthalmol; 2014 Jun 18; 49(3):308. PubMed ID: 24862783
    [No Abstract] [Full Text] [Related]

  • 18. Long-term course of antimalarial maculopathy after cessation of treatment.
    Easterbrook M.
    Can J Ophthalmol; 1992 Aug 18; 27(5):237-9. PubMed ID: 1393809
    [Abstract] [Full Text] [Related]

  • 19. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M.
    Can J Ophthalmol; 2014 Jun 18; 49(3):307-8. PubMed ID: 24862782
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.